Clinical Trial Update: Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers [Phase 4]

View source ↗

Summary

Phase 4 trial investigating an N-of-1 platform for cognitive enhancers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Performance

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Cognitive Performance | Phase 4 | Status: TERMINATED